Talacotuzumab, also known as JNJ-56022473 (and formerly CSL-362) is a humanized IgG1 monoclonal antibody designed to bind to and neutralize CD123 (Interleukin-3 receptor alpha chain or IL3RA) with potential antineoplastic activity.
货号（Catalog No.）
CSD00501
通用名INN
Talacotuzumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
产品描述(Description)
Talacotuzumab, also known as JNJ-56022473 (and formerly CSL-362) is a humanized IgG1 monoclonal antibody designed to bind to and neutralize CD123 (Interleukin-3 receptor alpha chain or IL3RA) with potential antineoplastic activity.
别名(Alternative names)
CSL-362-AML,CSL362,JNJ-56022473
靶点;物种(Specificity target name;species)
NOTCH2/ NOTCH3[Homo sapiens]
种类(Species)
Homo sapiens
受体鉴定(Receptor identification)
IgG2-kappa